Dynamics of tumor imaging with Gd‐DTPA—polyethylene glycol polymers: Dependence on molecular weight

Macromolecular contrast media offer potential advantages over freely diffusible agents in magnetic resonance (MR) imaging outside the central nervous system. To identify an optimum molecular weight for macromolecular contrast media, the authors studied a novel macromolecular contrast agent, gadolinium diethylenetriaminepentaacetic acid polyethylene glycol (DTPA‐PEG), synthesized in seven polymer (average) molecular weights ranging from 10 to 83 kd. Twenty‐eight rabbits bearing V2 carcinoma in thighs underwent T1‐weighted spin‐echo imaging before injection and 5–60 minutes and 24 hours after injection of the Gd‐DTPA‐PEG polymers or Gd‐DTPA at a gadolinium dose of 0.1 mmol/kg. Tumor region‐of‐interest measurements were obtained at each time point to determine contrast enhancement dynamics. Blood‐pool enhancement dynamics were observed for the Gd‐DTPA‐PEG polymers larger than 20 kd. Polymers smaller than 20 kd displayed dynamics similar to those of the freely diffusible agent Gd‐DTPA. Above the 20 kd threshold, tumor enhancement was more rapid for smaller polymers. The authors conclude that the 21.9‐kd Gd‐DTPA‐PEG polymer is best suited for clinical MR imaging.

[1]  M. Moseley,et al.  Evaluation of Gd-DTPA-labeled dextran as an intravascular MR contrast agent: imaging characteristics in normal rat tissues. , 1990, Radiology.

[2]  M. Moseley,et al.  Contrast-enhanced MRI of tumors. Comparison of Gd-DTPA and a macromolecular agent. , 1989, Investigative radiology.

[3]  P. Owren A quantitative one-stage method for the assay of prothrombin. , 1949, Scandinavian journal of clinical and laboratory investigation.

[4]  R. Brasch,et al.  Rationale and applications for macromolecular Gd‐based contrast agents , 1991, Magnetic resonance in medicine.

[5]  R. Brasch New directions in the development of MR imaging contrast media. , 1992, Radiology.

[6]  M. Moseley,et al.  Comparison of the contrast-enhancing properties of albumin-(Gd-DTPA) and Gd-DTPA at 2.0 T: and experimental study in rats. , 1986, AJR. American journal of roentgenology.

[7]  C. Sotak,et al.  Dependence of MR signal intensity on Gd tissue concentration over a broad dose range , 1991, Magnetic resonance in medicine.

[8]  W T Yuh,et al.  Use of MR imaging contrast agents in the brain , 1993, Journal of magnetic resonance imaging : JMRI.

[9]  R. Jain,et al.  Microvascular permeability of normal and neoplastic tissues. , 1986, Microvascular research.

[10]  M. Moseley,et al.  Macromolecular magnetic resonance imaging contrast media. Accumulated experience. , 1990, Investigative radiology.

[11]  U Schmiedl,et al.  Albumin labeled with Gd-DTPA as an intravascular, blood pool-enhancing agent for MR imaging: biodistribution and imaging studies. , 1987, Radiology.

[12]  U. Schmiedl,et al.  MRI of blood‐brain barrier permeability in astrocytic gliomas: Application of small and large molecular weight contrast media , 1991, Magnetic resonance in medicine.

[13]  D. Granger,et al.  4 – Permeability Characteristics of the Mircocirculation , 1983 .

[14]  H. Weinmann,et al.  In vivo and in vitro evaluation of Gd-DTPA-polylysine as a macromolecular contrast agent for magnetic resonance imaging. , 1991, Investigative radiology.

[15]  G. Arturson,et al.  THE RENAL CLEARANCE OF DEXTRAN OF DIFFERENT MOLECULAR SIZES IN NORMAL HUMANS. , 1964, Scandinavian journal of clinical and laboratory investigation.

[16]  R. Fulbright,et al.  Application of contrast agents in MR imaging of the spine , 1993, Journal of magnetic resonance imaging : JMRI.

[17]  M. Hashida,et al.  Macromolecules as Drug Delivery Systems , 1985 .